Scott Isaacs (@scottisaacsmd) 's Twitter Profile
Scott Isaacs

@scottisaacsmd

President @theaace, endocrinologist, obesity medicine, #MASLD, Emory Med School adjunct faculty. Posts are my own.

ID: 213754594

linkhttp://www.atlantaendocrine.com calendar_today09-11-2010 18:24:54

6,6K Tweet

16,16K Followers

2,2K Following

Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo
Scott Isaacs
@scottisaacsmd

4 days ago

Tirzepatide leads to greater weight loss and waist reduction than semaglutide at max doses. In a 72-week study, tirzepatide users lost up to 21% of body weight vs ~10% with semaglutide. More tirzepatide users hit ≥10%, 15%, 20%, and 25% weight loss targets. Waist circumference

Tirzepatide leads to greater weight loss and waist reduction than semaglutide at max doses. In a 72-week study, tirzepatide users lost up to 21% of body weight vs ~10% with semaglutide. More tirzepatide users hit ≥10%, 15%, 20%, and 25% weight loss targets. Waist circumference